Promtest is the leader in innovative approaches in diagnostics, being the official representative of the world-renowned brand “Abbott Diagnostics”. Promtest introduced quantitative and qualitative testing of hepatitis C into routine practice in 2008.

Promtest also introduced into routine practice the manual liquid-based cytology technique – a golden standard in oncocytology.

Nowadays, Promtest cooperates with leading laboratories such as the eX-Path laboratory in the Netherlands (IHC research), the BGI laboratory in Hong Kong (NIFTY – non-invasive fetal trisomy test), the DDC laboratory in the USA (genetic identification, disputed paternity, consanguinity identification).